Imaging, Diagnosis, Prognosis Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer

Purpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors.Weaimed to identify plasmamiRNAs that canbeused to differentiate patients with endometriosis and ovarian cancer from healthy individuals. Experimental Design: We conducted a two-stage exploratory study to investigate the use of plasma miRNA profiling to differentiate between patients with endometriosis, patients with endometriosisassociated ovarian cancer (EAOC), and healthy individuals. In the first stage, using global profiling of more than 1,000 miRNAs via reverse transcriptase quantitative PCR (RT-qPCR) in a 20-patient initial screening cohort, we identified 23 candidate miRNAs, which are differentially expressed between healthy controls (n 1⁄4 6), patients with endometriosis (n 1⁄4 7), and patients with EAOC (n 1⁄4 7) based on the fold changes. In the second stage, the 23 miRNAs were further tested in an expanded cohort (n1⁄4 88) of healthy individuals (n1⁄4 20), endometriosis (n1⁄4 33), EAOC(n1⁄4 14), and serous ovarian cancer cases (SOC; n1⁄4 21, included as controls). Results: We identified three distinct miRNA signatures with reliable differential expression between healthy individuals, patients with endometriosis, and patients with EAOC. When profiled against the control SOC category, our results revealed different miRNAs, suggesting that the identified signatures are reflective of disease-specific pathogenicmechanisms. Thiswas further supported by the fact that themajority of miRNAs differentially expressed in human EAOCs were mirrored in a double transgenic mouse EAOC